封面
市場調查報告書
商品編碼
2038948

人類生物樣本保存市場:按產品、生物檢體、保存方法、應用、最終用戶和地區分類

Human Biopreservation Market, By Offerings, By Biospecimen, By Preservation Method, By Application, By End User, By Geography

出版日期: | 出版商: Coherent Market Insights | 英文 168 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

預計到2026年,人類生物保存市場價值將達到57.832億美元,到2033年將達到116.98億美元。預計從2026年到2033年,該市場將以12.3%的複合年成長率成長。

報告範圍 報告詳情
基準年: 2025 2026年市場規模: 57.832億美元
歷史數據時期: 2020年至2024年 預測期: 2026年至2033年
2026年至2033年預測期間的複合年成長率: 12.30% 2033年市場規模預測: 116.98億美元

人體生物保存是生物技術與醫療保健產業的重要交叉領域。該市場涉及開發和提供各種技術,旨在透過將細胞、組織、器官和生物分子等生物材料冷卻至超低溫,使其保持惰性狀態。全球人體生物保存市場在確保生物樣本的長期儲存和保護方面發揮著至關重要的作用,這些樣本可用於再生醫學、藥物研發及其他領域的各種應用。

保存人體遺體的方法有很多,包括慢速冷凍、玻璃化冷凍和低溫療法等技術。這些技術特別應用於器官移植、幹細胞療法、輔助生殖技術、生物生物銀行和藥物研發等領域。受慢性病盛行率上升、器官移植需求增加、再生醫學投資不斷成長以及全球生物樣本庫發展等因素的推動,全球人體遺體保存市場預計將持續成長。

市場動態

由於全球器官移植數量的增加、幹細胞和再生醫學研究的進展、個人化醫療技術的進步以及全球生物樣本庫的成長,全球人體活體解剖市場正在穩步擴張。冷凍保存技術的進步、保存液的改進、政府對生物醫學研究的資助以及生育力保存技術的進步也是推動市場成長的因素。

然而,由於投資成本高、監管政策複雜、檢體儲存困難,以及開發中國家知識不足帶來的污染和設備故障風險,市場仍面臨許多限制因素。新的機會包括亞太和拉丁美洲市場的拓展、製藥公司與生物樣本庫的合作,以及罕見疾病和精準醫療等領域的應用擴展。

此外,將人工智慧 (AI) 和物聯網 (IoT) 融入監控程序,以及開發經濟高效的攜帶式技術,將有助於該行業的未來創新。

本次調查的主要特點

  • 本研究確定了各個細分市場的潛在商機,並說明了該市場具有吸引力的投資提案矩陣。
  • 此外,本研究還提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域展望以及主要參與者採取的競爭策略的重要見解。
  • 本研究根據以下參數對全球人類生物保存市場的主要參與者進行了分析:公司亮點、產品系列、主要亮點、財務表現和策略。
  • 透過利用本報告中的見解,企業行銷負責人和經營團隊將能夠就未來的產品發布、產品升級、市場擴張和行銷策略做出明智的決策。
  • 這份全球人類生物保存市場報告的目標受眾是該行業的各種相關人員,包括投資者、供應商、產品製造商、經銷商、新參與企業和金融分析師。
  • 透過分析全球人類生物保存市場中使用的各種策略矩陣,相關人員將能夠更輕鬆地做出決策。

目錄

第1章:研究目標與前提條件

  • 研究目標
  • 前提
  • 簡稱

第2章 市場範圍

  • 報告摘要
    • 市場定義和範圍
  • 執行摘要

第3章:市場動態、監管與趨勢分析

  • 市場動態
  • 影響分析
  • 主要亮點
  • 法規環境
  • 產品上市及核准
  • PEST分析
  • 波特的分析
  • 市場機遇
  • 法規環境
  • 主要進展
  • 產業趨勢

第4章 全球人體生物保存市場:依產品分類,2021-2033年

  • 設備和裝置
  • 培養基和試劑盒
  • 耗材和配件
  • 軟體/數位系統

第5章 全球人體活體解剖市場:依生物檢體,2021-2033年

  • 細胞
  • 生物液體
  • 組織

第6章 全球人體保存市場:依保存方法分類,2021-2033年

  • 冷凍保存
  • 玻璃化
  • 低溫保存
  • 其他

第7章 全球人體保存市場:依應用領域分類,2021-2033年

  • 生物銀行
  • 再生醫學
  • 研究
  • 其他用途

第8章 全球人類生物保存市場:依最終使用者分類,2021-2033年

  • 生物製藥公司
  • 合約研究組織(CRO)
  • 學術和研究機構
  • 醫院和生物樣本庫
  • 其他

第9章 全球人體活體解剖市場:依地區分類,2021-2033年,市場規模

  • 北美洲
    • 美國
    • 加拿大
  • 拉丁美洲
    • 巴西
    • 阿根廷
    • 墨西哥
    • 其他拉丁美洲
  • 歐洲
    • 德國
    • 英國
    • 西班牙
    • 法國
    • 義大利
    • 俄羅斯
    • 其他歐洲國家
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 澳洲
    • 韓國
    • ASEAN
    • 其他亞太地區
  • 中東
    • 海灣合作理事會國家
    • 以色列
    • 其他中東國家
  • 非洲
    • 南非
    • 北非
    • 中非

第10章 競爭格局

  • Thermo Fisher Scientific Inc.
  • Merck KGaA
  • Azenta Inc.
  • BioLife Solutions Inc.
  • Cryoport Inc.
  • Panasonic Healthcare Co. Ltd.
  • Lonza Group AG
  • Sartorius AG
  • Eppendorf AG
  • Chart Industries Inc.

第11章 分析師建議

  • 機會
  • 分析師意見
  • 連貫的機會地圖

第12章 參考文獻與調查方法

  • 參考
  • 調查方法
  • 關於本公司
簡介目錄
Product Code: CMI9435

Human Biopreservation Market is estimated to be valued at USD 5,783.2 Mn in 2026 and is expected to reach USD 11,698.0 Mn by 2033, growing at a compound annual growth rate (CAGR) of 12.3% from 2026 to 2033.

Report Coverage Report Details
Base Year: 2025 Market Size in 2026: USD 5,783.2 Mn
Historical Data for: 2020 To 2024 Forecast Period: 2026 To 2033
Forecast Period 2026 to 2033 CAGR: 12.30% 2033 Value Projection: USD 11,698.0 Mn

Human biopreservation represents an important intersection between biotechnology and the healthcare industry. The market concerns the development and provision of various techniques aimed at preserving living organisms or biological materials like cells, tissues, organs, and biomolecules in an inactive state through cooling them to ultra-low temperatures. The global human biopreservation market plays a crucial role in ensuring long-term storage and protection of biological samples for further use in various applications in regenerative medicine, pharmaceutical research, and other fields.

There are different ways of achieving human biopreservation, which involve such procedures as slow-rate freezing, vitrification, and hypothermia. They are specifically used in organ transplantations, stem cell therapy, reproductive technology, biobanking, and drug discovery among others. The global human biopreservation market is expected to develop due to the following driving factors: increasing prevalence of chronic diseases, the demand for organ transplantation, increasing investments in regenerative medicine, and growing biobanks globally.

Market Dynamics

The global human biopreservation market is expanding steadily due to rising organ transplantations, stem cell and regenerative medicine research, personalized medicine techniques, and biobank expansion worldwide. Cryopreservation technology development, advances in preservation media, government funding for biomedical research, and fertility preservation technology are other factors responsible for the growth of the market.

However, the market continues to face limitations owing to costly investments, regulatory policies, difficulties in preserving samples, and risks related to contamination and failure of equipment in developing countries with limited knowledge. New opportunities include increasing Asia Pacific and Latin American markets, collaboration among pharmaceutical firms and biobanks, and greater application of rare diseases and precision medicine treatments.

Furthermore, incorporation of artificial intelligence and the Internet of Things in monitoring procedures and development of cost-effective portable technologies will contribute to future innovation in the industry.

Key Features of the Study

  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global human biopreservation market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study include Thermo Fisher Scientific Inc., Merck KGaA, Azenta Inc., BioLife Solutions Inc., Cryoport Inc., Panasonic Healthcare Co. Ltd., Lonza Group AG, Sartorius AG, Eppendorf AG, and Chart Industries Inc.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The global human biopreservation market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global human biopreservation market

Market Segmentation

  • Offerings Insights (Revenue, USD Mn, 2021 - 2033)
    • Equipment and Instruments
    • Media and Kits
    • Consumables and Accessories
    • Software / Digital Systems
  • Biospecimen Insights (Revenue, USD Mn, 2021 - 2033)
    • Cells
    • Bio-Fluids
    • Tissues
  • Preservation Method Insights (Revenue, USD Mn, 2021 - 2033)
    • Cryopreservation
    • Vitrification
    • Hypothermic Storage
    • Others
  • Application Insights (Revenue, USD Mn, 2021 - 2033)
    • Biobanking
    • Regenerative Medicine
    • Research
    • Other Applications
  • End User Insights (Revenue, USD Mn, 2021 - 2033)
    • Biopharmaceutical Companies
    • Contract Research Organizations (CROs)
    • Academic and Research Institutes
    • Hospitals and Biobanks
    • Others
  • Regional Insights (Revenue, USD Mn, 2021 - 2033)
    • North America
    • U.S.
    • Canada
    • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
    • Europe
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
    • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
    • Middle East
    • GCC Countries
    • Israel
    • Rest of Middle East
    • Africa
    • South Africa
    • North Africa
    • Central Africa
  • Key Players Insights
    • Thermo Fisher Scientific Inc.
    • Merck KGaA
    • Azenta Inc.
    • BioLife Solutions Inc.
    • Cryoport Inc.
    • Panasonic Healthcare Co. Ltd.
    • Lonza Group AG
    • Sartorius AG
    • Eppendorf AG
    • Chart Industries Inc.

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Global Human Biopreservation Market, By Offerings
    • Global Human Biopreservation Market, By Biospecimen
    • Global Human Biopreservation Market, By Preservation Method
    • Global Human Biopreservation Market, By Application
    • Global Human Biopreservation Market, By End User
    • Global Human Biopreservation Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
  • Impact Analysis
  • Key Highlights
  • Regulatory Scenario
  • Product Launches/Approvals
  • PEST Analysis
  • PORTER's Analysis
  • Market Opportunities
  • Regulatory Scenario
  • Key Developments
  • Industry Trends

4. Global Human Biopreservation Market, By Offerings, 2021-2033, (USD Mn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2022 - 2033
    • Segment Trends
  • Equipment and Instruments
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
  • Media and Kits
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
  • Consumables and Accessories
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
  • Software / Digital Systems
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)

5. Global Human Biopreservation Market, By Biospecimen, 2021-2033, (USD Mn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2022 - 2033
    • Segment Trends
  • Cells
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
  • Bio-Fluids
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
  • Tissues
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)

6. Global Human Biopreservation Market, By Preservation Method, 2021-2033, (USD Mn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2022 - 2033
    • Segment Trends
  • Cryopreservation
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
  • Vitrification
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
  • Hypothermic Storage
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)

7. Global Human Biopreservation Market, By Application, 2021-2033, (USD Mn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2022 - 2033
    • Segment Trends
  • Biobanking
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
  • Regenerative Medicine
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
  • Research
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
  • Other Applications
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)

8. Global Human Biopreservation Market, By End User, 2021-2033, (USD Mn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2022 - 2033
    • Segment Trends
  • Biopharmaceutical Companies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
  • Contract Research Organizations (CROs)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
  • Academic and Research Institutes
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
  • Hospitals and Biobanks
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)

9. Global Human Biopreservation Market, By Region, 2021 - 2033, Value (USD Mn)

  • Introduction
    • Market Share (%) Analysis, 2026, 2029 & 2033, Value (USD Mn)
    • Market Y-o-Y Growth Analysis (%), 2022 - 2033, Value (USD Mn)
    • Regional Trends
  • North America
    • Introduction
    • Market Size and Forecast, By Offerings, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Biospecimen, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Preservation Method, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
      • U.S.
      • Canada
  • Latin America
    • Introduction
    • Market Size and Forecast, By Offerings, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Biospecimen, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Preservation Method, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
      • Brazil
      • Argentina
      • Mexico
      • Rest of Latin America
  • Europe
    • Introduction
    • Market Size and Forecast, By Offerings, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Biospecimen, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Preservation Method, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
      • Germany
      • U.K.
      • Spain
      • France
      • Italy
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, By Offerings, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Biospecimen, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Preservation Method, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
      • China
      • India
      • Japan
      • Australia
      • South Korea
      • ASEAN
      • Rest of Asia Pacific
  • Middle East
    • Introduction
    • Market Size and Forecast, By Offerings, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Biospecimen, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Preservation Method, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
      • GCC Countries
      • Israel
      • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, By Offerings, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Biospecimen, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Preservation Method, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Country/Region, 2021 - 2033, Value (USD Mn)
      • South Africa
      • North Africa
      • Central Africa

10. Competitive Landscape

  • Thermo Fisher Scientific Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Merck KGaA
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Azenta Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • BioLife Solutions Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Cryoport Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Panasonic Healthcare Co. Ltd.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Lonza Group AG
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Sartorius AG
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Eppendorf AG
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Chart Industries Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies

11. Analyst Recommendations

  • Wheel of Fortune
  • Analyst View
  • Coherent Opportunity Map

12. References and Research Methodology

  • References
  • Research Methodology
  • About us